De Novo Lipogenesis Maintains Vascular Homeostasis through Endothelial Nitric-oxide Synthase (eNOS) Palmitoylation*♦

Endothelial dysfunction leads to lethal vascular complications in diabetes and related metabolic disorders. Here, we demonstrate that de novo lipogenesis, an insulin-dependent process driven by the multifunctional enzyme fatty-acid synthase (FAS), maintains endothelial function by targeting endothelial nitric-oxide synthase (eNOS) to the plasma membrane. In mice with endothelial inactivation of FAS (FASTie mice), eNOS membrane content and activity were decreased. eNOS and FAS were physically associated; eNOS palmitoylation was decreased in FAS-deficient cells, and incorporation of labeled carbon into eNOS-associated palmitate was FAS-dependent. FASTie mice manifested a proinflammatory state reflected as increases in vascular permeability, endothelial inflammatory markers, leukocyte migration, and susceptibility to LPS-induced death that was reversed with an NO donor. FAS-deficient endothelial cells showed deficient migratory capacity, and angiogenesis was decreased in FASTie mice subjected to hindlimb ischemia. Insulin induced FAS in endothelial cells freshly isolated from humans, and eNOS palmitoylation was decreased in mice with insulin-deficient or insulin-resistant diabetes. Thus, disrupting eNOS bioavailability through impaired lipogenesis identifies a novel mechanism coordinating nutritional status and tissue repair that may contribute to diabetic vascular disease.

[1]  T. Hughes,et al.  Trafficking of Endothelial Nitric-oxide Synthase in Living Cells , 1999, The Journal of Biological Chemistry.

[2]  Timm Maier,et al.  The Crystal Structure of a Mammalian Fatty Acid Synthase , 2008, Science.

[3]  P. Shaul Regulation of endothelial nitric oxide synthase: location, location, location. , 2002, Annual review of physiology.

[4]  Michael E. Miller,et al.  Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.

[5]  M. Quon,et al.  Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. , 2000, Circulation.

[6]  D. Bredt,et al.  Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase , 2006, The Journal of cell biology.

[7]  A. Baron,et al.  Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. , 2000, Diabetes.

[8]  Hei Sook Sul,et al.  A Role of DNA-PK for the Metabolic Gene Regulation in Response to Insulin , 2009, Cell.

[9]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[10]  R. Knutsen,et al.  Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor–null mice , 2003, Nature Medicine.

[11]  J. Pankow,et al.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.

[12]  Jeffrey W. Smith,et al.  Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  A. Aljada,et al.  Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.

[14]  N. Toda,et al.  Phylogenesis of constitutively formed nitric oxide in non-mammals. , 2006, Reviews of physiology, biochemistry and pharmacology.

[15]  M. Moskowitz,et al.  Obesity Increases Vascular Senescence and Susceptibility to Ischemic Injury Through Chronic Activation of Akt and mTOR , 2009, Science Signaling.

[16]  Tiffany A. Miller,et al.  Insulin acutely decreases hepatic fatty acid synthase activity. , 2005, Cell metabolism.

[17]  S. Chirala,et al.  Fatty acid synthesis is essential in embryonic development: Fatty acid synthase null mutants and most of the heterozygotes die in utero , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Iwanaga,et al.  Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. , 2010, Cell metabolism.

[19]  T. Michel,et al.  Targeting and translocation of endothelial nitric oxide synthase. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[20]  M. Salis,et al.  Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice. , 2004, Diabetes.

[21]  R. Flavell,et al.  Conditional Vascular Cell Adhesion Molecule 1 Deletion in Mice , 2001, The Journal of experimental medicine.

[22]  M. Loda,et al.  Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer , 2008, Laboratory Investigation.

[23]  M. Zou,et al.  Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. , 2006, The Journal of clinical investigation.

[24]  T. Michel,et al.  Life history of eNOS: partners and pathways. , 2007, Cardiovascular research.

[25]  L. Ghiadoni,et al.  Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease , 2009, Diabetes Care.

[26]  S. Mader,et al.  Altered Endothelial Nitric Oxide Synthase Targeting and Conformation and Caveolin-1 Expression in the Diabetic Kidney , 2006, Diabetes.

[27]  C. Semenkovich,et al.  Getting away from glucose: stop sugarcoating diabetes , 2009, Nature Medicine.

[28]  G. Garcı́a-Cardeña,et al.  Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. , 1996, Biochemistry.

[29]  J. Schneider,et al.  "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.

[30]  Yoshiaki Suzuki,et al.  p260/270 Expressed in Embryonic Abdominal Leg Cells ofBombyx mori Can Transfer Palmitate to Peptides* , 1997, The Journal of Biological Chemistry.

[31]  Benjamin J. Kraus,et al.  Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory Network , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[32]  John P. Cooke,et al.  Murine Model of Hindlimb Ischemia , 2009, Journal of visualized experiments : JoVE.

[33]  A. Bailey,et al.  Palmitoylated proteins: purification and identification , 2007, Nature Protocols.

[34]  U. Förstermann,et al.  Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace , 2006, Circulation.

[35]  T. Tsuruo,et al.  De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy , 2009, British Journal of Cancer.

[36]  N. Hay,et al.  Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo , 2005, Nature Medicine.

[37]  S. Wakil,et al.  Fatty acid synthase, a proficient multifunctional enzyme. , 1989, Biochemistry.

[38]  S. Ropero,et al.  Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Garcı́a-Cardeña,et al.  Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Tsai,et al.  Three Different Oxygen-induced Radical Species in Endothelial Nitric-oxide Synthase Oxygenase Domain under Regulation by L-Arginine and Tetrahydrobiopterin* , 2004, Journal of Biological Chemistry.

[41]  J. Banchs,et al.  Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium. , 2002, Journal of applied physiology.

[42]  M. Schuler,et al.  Peptides from purified soybean β‐conglycinin inhibit fatty acid synthase by interaction with the thioesterase catalytic domain , 2010, The FEBS journal.

[43]  Marjana Tomic-Canic,et al.  Cellular and molecular basis of wound healing in diabetes. , 2007, The Journal of clinical investigation.